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Abstract
Glaucoma is characterized by the progressive dysfunction and loss of retinal ganglion cells. 
However, the earliest degenerative events that occur in human glaucoma are relatively 
unknown. Work in animal models has demonstrated that retinal ganglion cell dendrites remodel 
and atrophy prior to the loss of the cell soma. Whether this occurs in human glaucoma has yet 
to be elucidated. Serial block face scanning electron microscopy is well established as a method 
to determine neuronal connectivity at high resolution but so far has only been performed in 
normal retina from model animals. To assess the structure-function relationship of early human 
glaucomatous neurodegeneration, regions of inner retina assessed to have none-to-moderate 
loss of retinal ganglion cell number were processed using serial block face scanning electron 
microscopy (n = 4 normal retinas, n = 4 glaucoma retinas). This allowed detailed 3D 
reconstruction of retinal ganglion cells and their intracellular components at a nanometer scale. 
In our datasets retinal ganglion cell dendrites degenerate early in human glaucoma, with 
remodeling and redistribution of the mitochondria. We assessed the relationship between visual 
sensitivity and retinal ganglion cell density and discovered that this only partially conformed 
to predicted models of structure-function relationships, which may be affected by these early 
neurodegenerative changes. In this study, human glaucomatous retinal ganglion cells 
demonstrate compartmentalized degenerative changes as observed in animal models. 
Importantly, in these models, many of these changes have been demonstrated to be reversible, 
increasing the likelihood of translation to viable therapies for human glaucoma. 
Key words: Glaucoma, retinal ganglion cell, electron microscopy, dendrite, mitochondria 
Abbreviations: Area under the curve (AUC), ganglion cell layer (GCL), intraocular pressure 
(IOP), nearest neighbor distance (NND), optical coherence tomography (OCT), primary open 
angle glaucoma (POAG), serial block face scanning electron microscopy (SBFSEM)
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Introduction
With an estimated 70 million patients worldwide, glaucoma remains a leading cause of 
irreversible blindness and a major economic burden (Tham et al. 2014). The earliest detectable 
neurodegenerative changes in human patients are yet to be fully elucidated, but their discovery 
could provide novel biomarkers to support early diagnosis and treatment. 
Glaucoma is characterized by the progressive dysfunction and death of retinal ganglion cells. 
Age, genetics, and elevated intraocular pressure (IOP) are prominent risk factors for the 
development of human glaucoma. Animal models of glaucomatous ocular hypertension (which 
recapitulate the elevated IOP risk factor seen in many glaucoma patients) have demonstrated 
that retinal ganglion cell mitochondrial abnormalities (Williams, Harder, Foxworth, Cochran, 
et al. 2017), synapse loss (Della Santina et al. 2013, Berry et al. 2015, Williams et al. 2016), 
and dendritic atrophy (Williams, Howell, et al. 2013) precede cell death. These disease features 
have been demonstrated across model species; in mouse (Leung et al. 2011, Feng et al. 2013, 
Williams, Howell, et al. 2013, Berry et al. 2015), rat (Williams et al. 2016, Morgan et al. 2006, 
Urcola, Hernandez, and Vecino 2006), cat (Shou et al. 2003), and non-human primate (Weber, 
Kaufman, and Hubbard 1998, Morgan, Uchida, and Caprioli 2000). Importantly, whereas axon 
regeneration does not occur in the mammalian optic nerve; retinal ganglion cell dendritic and 
synaptic plasticity, regrowth, and re-innervation could underpin visual recovery during early 
human glaucoma. However, there is no evidence that these degenerative changes occur as an 
early feature of human glaucoma, with only a single study showing dendritic loss in eyes which 
had progressed to complete blindness (Pavlidis et al. 2003). Current evidence of retinal 
ganglion cell death in glaucoma comes from cell counts in donor tissue (Quigley, 
Dunkelberger, and Green 1989), live imaging of apoptosis (Cordeiro et al. 2017), and retinal 
nerve fiber layer thinning (retinal ganglion cell axons in the inner retina) measured by optical 
coherence tomography (OCT) (Raza et al. 2011). Clinical measures of vision loss come from 
functional tests, in which deficits at the level of single retinal ganglion cells could be masked 
through the summation of outputs in the visual centers of the brain (Redmond et al. 2010, 
Mulholland et al. 2015).
In routine clinical practice, visual function is measured in glaucoma by Standard Automated 
Perimetry in which spot stimuli of modulated luminance are presented to determine visual 
sensitivity at specific locations in the visual field. Although this technique is regarded as a gold 
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standard clinical test of visual function in glaucoma, it has poor sensitivity to early disease 
(Tafreshi et al. 2009) and high variability confounding the identification of statistically 
significant visual deterioration (Artes et al. 2002). The ‘hockey-stick’ model of Swanson et al. 
(Swanson, Felius, and Pan 2004) describes the relationship between visual field sensitivity and 
retinal ganglion cell density in healthy eyes. It predicts that the rate of change in sensitivity 
with respect to retinal ganglion cell number is low when the stimulus is larger than the critical 
summation area (2.5 dB loss per log unit reduction in cell number) and increases when the 
stimulus is smaller than the critical summation area (10 dB loss per log unit reduction in cell 
number; i.e. a 1:1 relationship since 1 dB = 0.1 log unit attenuation of stimulus luminance from 
the maximum). Since the perimetric stimuli are of fixed area and the critical summation area 
is known to enlarge in early glaucoma (Redmond et al. 2010), the ‘hockey-stick’ model predicts 
an initial slow decline in visual field sensitivity when the remaining retinal ganglion cell 
density is high, followed by a steep decline once substantial retinal ganglion cell loss has 
occurred. When sensitivity loss is mild, early neurodegenerative changes may be masked by 
spatial summation, and within- and between-test variability when assessed by Standard 
Automated Perimetry.
To assess the structure-function relationship of early human glaucomatous neurodegeneration, 
we used two-photon imaging of regions of whole human control and glaucomatous retina to 
determine the relationship between retinal ganglion cell loss and visual field sensitivity (as 
assessed by Standard Automated Perimetry). Regions of inner retina assessed to have none-to-
moderate cell loss and visual deficit were processed using serial block face scanning electron 
microscopy (SBFSEM) to generate detailed 3D reconstructions of retinal ganglion cells and 
their intracellular components at a nanometer scale. This automated approach has been used to 
great effect to generate and analyze large scale retinal connectomes in normal animal tissue 
(Briggman, Helmstaedter, and Denk 2011, Helmstaedter et al. 2013) and to investigate 
pathophysiological changes to single neurons in other neurodegenerations (Giacci et al. 2018, 
Yamasaki et al. 2014). We applied these methods to quantify mitochondrial and dendritic 
abnormalities in regions of no-to-moderate visual deficit in the human glaucomatous retina. To 
date, no studies of human glaucomatous retinal ganglion cells have been undertaken using 
SBFSEM, and as such, this study represents the first attempt to resolve human retinal ganglion 
cells and their intracellular components in 3-dimensions at this scale.
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Materials and Methods
Human tissue
Donor tissue was obtained from the Minnesota Lions Eye Bank (St. Paul, MN, USA) in 
accordance with local ethical approval. Donor eyes (n = 4 eyes; mean age 74.5 y) with primary 
open angle glaucoma (POAG) and controls (n = 8 eyes; mean age 81.6 y) were used. Posterior 
globes were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer within 24 hours of the 
recorded time of death and then transferred to Cardiff University, UK and stored at 4 ˚C until 
used. Work carried out in Cardiff was in compliance with the UK Human Tissue Act 2004. 
Donor information is summarized in Table 1. The four glaucomatous eyes had corresponding 
visual field tests (Humphrey Field Analyzer (HFA II, Carl Zeiss Meditec, Dublin, CA; SITA-
Standard, 24-2 test pattern, Goldmann III stimulus, and 200ms duration) undertaken 7-21 
months before death.
Table 1: Donor details
Sample 
ID
Eye Condition Sex Age Time 
from 
death to 
fixation 
(hours)
Time in 
fixation 
prior to 
study 
(years)
Time 
from 
visual 
field test 
to death 
(months)
IOP 
(mmHg) 
at a) 12,
b) 6, c) 0 
months 
prior to 
field test
Usage:
1. Cell 
counts
2. 
SBFSEM
GL239 L Glaucoma 
(POAG)
M 77 3.83 4-3.5 21 a) 10
b) 13
c) 17
1, 2
GL239 R Glaucoma
(POAG)
M 77 3.83 4-3.5 21 a) 13
b) 14
c) 17
1, 2
GL277 L Glaucoma 
(POAG)
F 72 2.3 1.5-3.5 7 a) NA
b) 21
c) 13
1, 2
GL277 R Glaucoma 
(POAG)
F 72 2.3 1.5-3.5 7 a) NA
b) 21
c) 13
1, 2
14-0625 R Control F 83 6.5 1.5-3.5 NA NA 1, 2
14-1137 L Control F 83 9 1.5-3.5 NA NA 2
14-0899 L Control M 86 6.5 1.5-3.5 NA NA 1, 2
16-1025 R Control M 83 7.33 2 NA NA 2
14-1357 L Control M 82 12 1.5 NA NA 1
14-1396 R Control M 82 8 1.5 NA NA 1
14-1398 R Control M 88 9.5 1.5 NA NA 1
14-0865 R Control M 66 10.5 1.66 NA NA 1
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Two-photon imaging and cell counting
Whole retinae (n = 4 for glaucoma, n = 6 for control) were dissected free from the globes and 
stained overnight at 4 °C with 1 µg/ml Hoechst 33342 stain (Life Technologies, H1399). A 
custom two-photon microscope comprising a moveable objective microscope (MOM®, Sutter 
Instruments) and Ti:Sapphire laser (MaiTai DeepSee, Newport Spectra-Physics) was used to 
collect images of 54 retinal regions corresponding to the visual field test locations (Figure 1A). 
Retinal distances were taken from the centre of the optic nerve head and measured using a 
stepper driven stage. Z-stack images (5 µm slices from retinal nerve fiber layer to top of inner 
nuclear layer) were collected at 40x, giving an en face sample area of 350µm2 for each of the 
54 regions. All Hoechst positive nuclei within 3 sampling regions of 200 x 200 pixels were 
counted manually using the cell counter plugin for FIJI (Schindelin et al. 2012) and averaged 
to provide an estimate of cells / mm2 for each of the 54 regions. Only round medium-to-large 
cell nuclei were counted (to exclude vascular endothelial cells identified by their more prolate 
nuclei). A correction to account for displaced amacrine cells in the ganglion cell layer (GCL) 
based on Curcio and Allen (1990) was applied to each test region in control retina. The average 
number of amacrine cells at each test location was then calculated and subtracted from the cell 
count for corresponding regions in glaucomatous retina.
Comparison of retinal ganglion cell density and visual field sensitivity
Pointwise visual field sensitivity values were plotted against log retinal ganglion cell density 
(cells/mm2). Log retinal ganglion cell density was calculated as the number of cells underlying 
the Goldmann III stimulus (0.431° diameter), using the method outlined by Garway-Heath et 
al. (Garway-Heath et al. 2000). The area of a Goldmann III stimulus at the fovea is 0.012 mm2 
(using the conversion factor q = 0.286 mm/°) (Garway-Heath et al. 1998). A correction was 
applied to account for an altered stimulus area with increasing eccentricity from the fovea 
(Holden and Fitzke 1988) calculated with the equation: qp = qo - 0.000014U2, where qp = 
conversion factor for locations outside the fovea, qo = conversion factor at the fovea, and U = 
eccentricity in degrees. Pointwise visual field data were corrected for an expected deterioration 
in sensitivity as a function of age (but not of disease) between the time of the visual field 
assessment and death, using the age slopes provided by Heijl et al. (Heijl, Lindgren, and Olsson 
1987). In order to compare with the ‘hockey-stick’ model, sensitivity values from the current 
study were adjusted upwards by 0.9dB, to account for the expected difference between values 
from examinations performed with the SITA-Standard strategy and the full threshold strategy. 
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Electron microscopy
Eleven retinal regions corresponding to visual field test locations with no to moderate cell loss 
and visual deficit were dissected free (n = 4 retinae, n = 5 regions for glaucoma; n = 4 retinae, 
n = 6 regions for control). These regions are overlaid on the visual field plots for glaucomatous 
eyes in Figure 1A; control regions were matched locations. The retinal regions were washed 
in 0.2 M sodium cacodylate buffer for 2 days before further fixation in 2.5 % glutaraldehyde / 
2 % PFA in sodium cacodylate buffer. The tissue was then infiltrated with 1.5 % potassium 
ferricyanide (Arcos) / 1 % osmium tetroxide (Agar Scientific, UK) in 0.1 M sodium cacodylate 
buffer, 1 % thiocarbohydrazide (Sigma), 1 % osmium tetroxide, 1 % uranyl acetate (TAAB, 
Aldermaston, UK), and Walton’s lead aspartate (Agar Scientific) with intermittent washes with 
distilled water. The tissue was dehydrated through a series of ethanol concentrations followed 
by propylene oxide and infiltration with Araldite CY212 resin and dodecenyl succinic 
anhydride mix (Agar Scientific). The resin was changed 14 times over 3 days before embedding 
the tissue in moulds and curing at 60 ˚ C for 48 h. The resin blocks were then trimmed and glued 
to cryopins (Leica Microsystems (UK) Ltd, Milton Keynes, UK). Glass knives were created 
using a Leica EM KMR2 and the tissue block planed on a UCE ultramicrotome (Reichert-Jung, 
Cambridge, UK). Conducting carbon cement (Agar Scientific) was applied to avoid charging 
and resultant damage to the block during imaging before gold coating using an ACE600 
sputtercoater (Leica Microsystems). SBFSEM was performed using a Zeiss Sigma FEG 
scanning electron microscope (SEM; Carl Zeiss, Cambridge, UK), with attached 3View®2 
system (Gatan, Pleasanton, CA). 500-1000 slices (100 nm thickness) were removed from the 
block surface by an in-chamber ultramicrotome, each alternating with automated imaging of 
the remaining block face (79 x 79 µm) to generate an aligned data set with a voxel resolution 
of 19.2 x 19.2 x 100 nm. 
3D data analysis
Retinal ganglion cells were identified and segmented using the TrakEM2 plugin (Cardona et 
al. 2012) for FIJI. Due to the block size and the relative low cell density, analysis was focused 
on midget retinal ganglion cells (Figure 2C, see also (Kolb and Dekorver 1991, Kolb, Linberg, 
and Fisher 1992)), the predominant retinal ganglion cell sub-type in the human retina (~80% 
of retinal ganglion cells (Dacey 1993)). Dendrites were segmented separately and the dendritic 
length measured. Mitochondria (identified by the presence of cristae) and vacuoles (identified 
as a double membranous structure without multi-lamellar structures, and without easily 
identifiable electron dense material) were segmented. The Cartesian co-ordinates of each 
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mitochondrion and vacuole were recorded. The distribution of these organelles was measured 
as the distance from the soma center along the dendrite and expressed as a Sholl profile 
(frequency at binned distances), from which an area under the curve (AUC) was derived. 
Nearest neighbor distances (NND; as Euclidean distances) were calculated for individual 
mitochondria and vacuoles within primary, secondary and tertiary dendrites using SPSS nearest 
neighbor distance analysis (k = 3). Individual morphometric analysis of mitochondria was 
performed using Imaris (Bitplane). New surfaces were generated for individual mitochondria 
and volume, sphericity, oblate ellipticity, and prolate ellipticity calculated for each 
mitochondrion. 
Statistical analysis
The sample size (n) is shown in each figure legend. Graphing and statistical analysis was 
performed in R and IBM SPSS statistics 23. Statistical tests are indicated at the point of usage 
within the methods and results. Sholl distributions of mitochondria and vesicles, and dendrite 
composition (primary, secondary, and tertiary expressed as a percentage of total) were 
compared between control and glaucoma using Fisher's exact test in R. Multiple regression 
analysis was performed to determine if tissue sampling and quality (eccentricity from macula, 
time from death to fixation, time in fixation prior to EM processing and donor age; independent 
variables) influenced dendritic size and branch, mitochondrial and vacuole number, volume 
and distribution (dependent variables). Analysis was performed in R using the lm function (R 
stats package) and zero-order correlations were calculated using the calc.relimp function 
(relaimpo package; (Grömping 2006)) on z-scores. For box plots, the center hinge represents 
the mean with upper and lower hinges representing the first and third quartiles; whiskers 
represent 1.5 times the interquartile range. Unless otherwise stated in the figure legends; * = P 
< 0.05, ** = P < 0.01, *** = P < 0.001.
Data availability
All the data is presented in full in this manuscript.
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Results
Visual sensitivity measured by Standard Automated Perimetry does not accurately predict the 
degree of retinal ganglion cell loss in glaucoma
Retinal ganglion cell loss in human glaucoma samples was first assessed by two-photon 
imaging of Hoechst labeled nuclei. The relationship between cell density and visual sensitivity 
(identified by Standard Automated Perimetry prior to death) was determined. Two-photon z-
stack images from whole-mount retinas were collected from 54 regions that corresponded to 
visual field test locations (Figure 1A). Average cell counts revealed that cell density in the 
retinal ganglion cell layer was reduced in glaucomatous eyes by 28% compared to controls 
when averaged across all regions (P < 0.001; Mann-Whitney). Heat-maps of individual eyes 
demonstrated that the loss was diffuse and did not qualitatively resemble the corresponding 
visual field plots (Figure 1B). Density reduction was best matched in regions where field loss 
was moderate, but this did not reflect regions of more advanced, arcuate field loss (Figure 1B). 
Importantly, the retinal ganglion cell density in the control retinas matched those reported by 
Curcio and Allen (Curcio and Allen 1990) (Figure 1C). The relationship between visual field 
sensitivity and the number of retinal ganglion cells underlying the perimetric stimulus (log10 
cells per Goldmann III stimulus area) was highly non-linear in eyes with glaucoma 
(Spearman’s rho, r = 0.23, P < 0.001) (Figure 1C-D). The relationship was similar to the 
‘hockey-stick’ model in regions where visual deficit was less pronounced (i.e. a shallow 
relationship when retinal ganglion cell density is high), but a steeper than expected drop-off in 
sensitivity in regions with lower retinal ganglion cell density (Figure 1D). 
Retinal ganglion cell dendritic remodeling occurs early in human glaucoma
For detailed analysis of retinal ganglion cell dendrites and their ultrastructure, five regions 
corresponding to visual field test locations (and six from region- and age- matched control 
eyes; locations shown in Figure 1A; lower row) were processed for serial block face scanning 
electron microscopy (SBFSEM) to generate 79 x 79 x 100 µm cubes of retinal data (Figure 
2A; representative single slice (cropped area) shown in Figure 2B). Retinal ganglion cells were 
identified by the presence of an initial axon segment and were required to have a primary 
dendrite in order to be processed for further analysis (amacrine cells, the other major cell 
population of the inner retina, lack an axon, and so were not included). Only midget retinal 
ganglion cells, comprising ~80% of the retinal ganglion cell population in the human retina, 
(Dacey 1993) were processed. In addition, due to their larger dendritic field size, complete 
https://mc.manuscriptcentral.com/braincom
D
ow
nloaded from
 https://academ
ic.oup.com
/braincom
m
s/advance-article-abstract/doi/10.1093/braincom
m
s/fcz035/5645163 by guest on 05 D
ecem
ber 2019
parasol retinal ganglion cells were less likely to be captured within individual SBFSEM 
datasets.  Confirmed midget retinal ganglion cells were reconstructed in 3D (example in Figure 
2C) allowing for measurements of dendritic length, volume, and surface area. Seven control 
retinal ganglion cells (5 ON center, 2 OFF center; dendrites shown in Figure 2D, upper panel) 
and five glaucomatous retinal ganglion cells (5 ON center; dendrites shown in Figure 2D, 
lower panel) were identified. To account for dendritic field size differences between ON and 
OFF center cells, measurements (dendrite, synapse, mitochondria, and vacuole) were 
normalized to the total dendritic length of the cell. There was no significant difference in the 
average volume of the dendritic tree (P = 0.876) or the average surface area (P = 0.530) in 
glaucomatous retinal ganglion cells compared to controls, however, retinal ganglion cells from 
glaucomatous regions of the retina had 69% fewer dendritic branches than those from control 
tissue (P = 0.048; Mann-Whitney; Figure 2E). The proportions of primary, secondary and 
tertiary dendrites were significantly altered in glaucoma (P < 0.0001; Fisher's exact test; 
Figure 2F). Secondary and tertiary dendritic length was reduced suggesting dendrite retraction 
prior to gross dendritic loss (P = 0.036 and 0.049 respectively; Figure 2G). To account for 
changes to dendrites driven by age-related or tissue processing factors we performed multiple 
regression analysis. Multiple regression analysis revealed that differences in dendritic 
branching and length were not driven by variation in tissue fixation times, age of the donor, or 
the foveal eccentricity of the retinal ganglion cell analysed (Table 2). Time to fixation and 
donor age had a statistically significant effect on variance in dendrite volume (accounting for 
up to 35% (P = 0.008) and 12% (P = 0.022) of variance respectively). However, we saw no 
statistically significant difference in dendrite volume between control and glaucoma retinal 
ganglion cells in our morphological analysis.
Changes to mitochondria and vacuoles in glaucomatous retinal ganglion cell dendrites
Mitochondrial abnormalities and dysfunction are likely to be early features of human glaucoma 
and a systemic vulnerability to mitochondrial abnormalities has been reported in glaucoma 
patients (Osborne, Nunez-Alvarez, et al. 2016). SBFSEM reconstructions allowed the analysis 
of mitochondrial morphology and distribution within retinal ganglion cell dendrites (examples 
and reconstructions shown in Figure 3A-D). Glaucomatous retinas had a reduced number of 
mitochondria within retinal ganglion cells (-62%, P = 0.048, Mann-Whitney) and occupied 
74% less of the dendritic volume compared to those of controls (P = 0.003) (Figure 3E-F). 
Mitochondria demonstrated an altered distribution across dendrites (as assessed by Sholl 
analysis; Figure 3G-J). Mitochondrial distribution was significantly reduced in secondary 
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dendrites (Sholl AUC; P < 0.0001, Mann-Whitney) with a significantly altered distributions 
across the Sholl analyses (P < 0.0001; Fisher's exact test; Figure 3H and J). Nearest neighbor 
distance analysis of individual mitochondria within dendrites demonstrated no significant 
increase in distance between the three nearest neighbors (k = 3) for mitochondria within 
primary dendrites (k-1; P = 0.711, k-2; 0.901, k-3; 0.921; Mann-Whitney), but a substantial 
increase in nearest neighbor distances in secondary dendrites (P < 0.0001 for k-1, k-2, k-3) 
indicating that mitochondria become increasingly isolated in more peripheral dendritic 
segments (Figure 3K-M). 
We next assessed the morphology of individual mitochondria within retinal ganglion cells. 
Smaller mitochondria have previously been observed in ophthalmic and neurodegenerative 
diseases (including glaucoma) and are typically indicative of a mitochondrial fusion / fission 
imbalance and / or an imbalance in mitophagy (Williams et al. 2012, Williams, Harder, 
Foxworth, Cochran, et al. 2017, Coughlin et al. 2015, Kong et al. 2009, Knott et al. 2008). 
Shape factor analysis revealed that individual mitochondria were smaller (53%, P = 0.008, 
Student’s t-test) and more rounded (9%, P = 0.010) in glaucomatous retinal ganglion cells 
compared to those in controls (Figure 3N-P). This is consistent with mitochondrial 
morphological changes demonstrated in model hypoxia systems (Ahmad et al. 2013, Campello 
and Scorrano 2010, Fuhrmann and Brune 2017, Zhang et al. 2018) and other groups have 
demonstrated that glaucomatous retinal ganglion cells likely undergo chronic intermittent 
hypoxia following periods of elevated IOP (Chidlow, Wood, and Casson 2017, Holcombe et 
al. 2008, Tezel and Wax 2004). Mitochondria in glaucomatous retinal ganglion cells had no 
significant changes to oblate (rounded; 1%, P = 0.984) or prolate ellipticity (cigar-shaped; 11%, 
P = 0.76; Figure 3Q). 
Other double membranous structures (within the size range of 0.1-5 µm) were grouped and 
segmented. These comprised small vacuoles, granulovacuolar degeneration bodies containing 
only small quantities of electron dense material, and mitochondria devoid of cristae structure 
(examples in Figure 3A and C). The appearance of vacuoles is an age and disease related 
change observed in neurons in aged rodents (de Estable-Puig and Estable-Puig 1975) and post-
mortem human tissue from various dementias (Ball 1977, Nakamori et al. 2013). 
Granulovacuolar degeneration bodies, a hallmark of Alzheimer’s disease, are late stage 
autophagocytic vacuoles, the accumulation of which may relate to incomplete autophagy 
(Funk, Mrak, and Kuret 2011). Mitochondria devoid of cristae have been reported in animal 
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models of glaucoma (Williams, Harder, Foxworth, Cochran, et al. 2017, Coughlin et al. 2015) 
and other neurodegenerations (Baloyannis 2011, Williams et al. 2012, Franco-Iborra, Vila, and 
Perier 2018). In the present study we could not confidently separate these structures and so 
grouped them as vacuoles to generate a meaningful index of degeneration. We observed that 
these vacuoles occupied 12% of the dendritic volume in glaucoma and 8% in control retinal 
ganglion cells (P = 1.00, Mann-Whitney; Figure 3E and F). These structures increased in 
frequency by 40% in glaucomatous retinal ganglion cells compared to controls (P = 0.048, 
Mann-Whitney) and were distributed along a higher proportion of the dendritic tree (as shown 
by Sholl AUC; 62% increase, P = 0.073, Mann-Whitney; and as assessed by Fisher's exact test, 
P < 0.0001; Figure 3R and S). Nearest neighbor distance analysis (Figure 3T) demonstrated 
a decrease in distance between individual vacuoles in glaucomatous retinal ganglion cells (P < 
0.0001 for k-1, k-2, k-3; Mann-Whitney). These findings are consistent with imbalanced fusion 
/ fission and autophagy, and are an indicator of increased neurodegenerative insults in 
glaucomatous retinal ganglion cells. 
We performed multiple regression analysis to determine whether age-related or tissue 
processing factors influenced mitochondria and vacuole metrics. Multiple regression analysis 
demonstrated that differences in mitochondrial and vacuole number, volume and distribution 
were not driven by variation in tissue fixation times, age of the donor or the foveal eccentricity 
of the retinal ganglion cell analysed (Table 2). No statistically significant model was produced 
and all showed weak correlation (all R2 < 0.625, P > 0.1). Time to fixation and donor age had 
a statistically significant effect on variance in total vacuole volume (accounting for up to 34% 
(P = 0.019) and 5% (P = 0.029) of variance respectively). The magnitude of change between 
control and glaucoma vacuole volume may therefore be overestimated in these data due to the 
variability of tissue, but are not the predominant determinant of difference. 
Collectively, these data demonstrate that following periods of elevated IOP, retinal ganglion 
cell dendrites degenerate prior to gross cell loss with marked changes to mitochondrial 
frequency and density. 
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Table 2: Multiple regression analysis
Dependent variable
Dendrite 
branches
Dendrite 
volume
Dendrite 
length
Mito. 
number
Total 
mito. 
volume
Total 
mito. 
SAUC
Vacuole 
number
Total 
vacuole 
volume
Total 
vacuole 
SAUC
R2
0.685 0.745 0.639 0.508 0.499 0.492 0.489 0.624 0.461
Adj. R2
0.598 0.599 0.433 0.227 0.212 0.201 0.198 0.409 0.153
P
0.060 0.030 0.092 0.232 0.245 0.255 0.258 0.104 0.301
O
ve
ra
ll 
re
gr
es
si
on
 
m
od
el
Intercept 
coef. 1.98 1144.42 204.21 58.37 53.47 374.42 604.94 156.48 3291.80
Variable 
coef. -0.02 -3.52 -0.77 1.33 0.04 5.93 -0.66 -0.33 -5.87
Contribu-
tion (%) 13.4 27.2 17.5 0.1 5.4 0.2 6.3 22.0 3.2
E
cc
en
tr
ic
ity
P
0.687 0.228 0.275 0.304 0.884 0.368 0.683 0.409 0.510
Variable 
coef. 0.30 46.29 6.98 7.42 2.92 36.92 8.01 5.51 42.52
Contribu-
tion (%) 27.7 35.1 25.7 20.0 26.3 19.0 12.7 34.2 10.7
T
im
e 
to
 
fix
at
io
n
P
0.115 0.008 0.055 0.236 0.069 0.249 0.320 0.019 0.332
Variable 
coef. 0.10 27.33 -0.37 -5.99 0.53 -33.26 -5.67 2.19 -43.01
Contribu-
tion (%) 5.7 0.5 8.0 18.9 6.9 18.9 0.3 1.3 0.2
T
im
e 
in
 
fix
at
iv
e
P
0.679 0.165 0.940 0.476 0.789 0.443 0.599 0.419 0.470
Variable 
coef. -0.03 -16.96 -2.54 -1.15 -0.87 -6.51 -7.17 -2.27 -38.40
Contribu-
tion (%) 21.7 11.7 12.6 11.8 11.3 11.0 29.7 4.8 32.0
In
de
pe
nd
en
t v
ar
ia
bl
es
A
ge
P
0.663 0.022 0.113 0.676 0.206 0.645 0.074 0.029 0.079
Adj. = adjusted; Coef. = coefficient; mito. = mitochondria; SAUC = Sholl area under the curve
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Discussion
Retinal connectomics by electron microscopy or genetic labeling has established itself as the 
technique to dissect neuronal tracts and pathways in detail. These studies are usually 
undertaken using specially prepared tissue from model animals, in either normal or developing 
retina (Briggman, Helmstaedter, and Denk 2011, Helmstaedter et al. 2013, Greene et al. 2016, 
Kim et al. 2014, Marc et al. 2014). Due to the time-to-fixation, human donor tissue from 
glaucoma patients has typically been of insufficient quality to enable neuronal analysis. A short 
time-to-fixation is key in preserving neuronal integrity, but prolonged fixation raises 
considerable technical challenges with standard techniques for visualizing neurons (e.g. Golgi 
staining, intracellular filling, DiOlistic labelling (Dowling 2012, Balendra et al. 2015)). We 
sought to overcome these challenges by using rare tissue with a shorter post-death time-to-
fixation (average ~6 hours) than typical for post-mortem tissue, and specifically selecting 
regions of retina with known clinical history (in particular, visual field sensitivity data) and 
known retinal ganglion cell densities (determined histologically).
Retinal ganglion cell degeneration in glaucoma is a compartmentalized process, with different 
factors affecting different compartments of the cell (axon, soma, dendrites, synapses, and 
mitochondria) (Whitmore, Libby, and John 2005, Williams, Harder, Foxworth, Cardozo, et al. 
2017, Della Santina and Ou 2017). However, our knowledge of this compartmentalized 
degeneration comes primarily from animal models with only limited data from human tissue 
(Morrison et al. 2005, Wang et al. 2003). In our dataset, human glaucomatous retinal ganglion 
cells undergo dendritic and mitochondrial changes. Given the presence of dendritic 
degeneration, it is reasonable to conclude that these RGCs have less synaptic contacts, but this 
could not be definitively assessed in these datasets due to the available resolution of SBFSEM 
when capturing large image volumes. Further studies on single retinal ganglion cells with 
higher resolution and higher throughput methods are warranted to explore synapses at this 
level. Synapse loss prior to marked neurodegeneration has been demonstrated in animal models 
of glaucoma (Williams et al. 2016, Della Santina et al. 2013, Berry et al. 2015) and is a common 
feature of other neurodegenerations (Reddy et al. 2012, Williams et al. 2012). The process is 
predicted to be an early driver of visual dysfunction in glaucoma.
Reduction in mitochondrial volume and distribution may indicate that glaucomatous retinal 
ganglion cells are under increased metabolic strain, an emerging aspect of early glaucomatous 
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degeneration in animal models (Williams, Harder, Foxworth, Cochran, et al. 2017, Williams, 
Harder, Foxworth, Cardozo, et al. 2017, Inman and Harun-Or-Rashid 2017, Osborne, Nunez-
Alvarez, et al. 2016, Baltan et al. 2010, Ebneter et al. 2011). Furthermore, genomic analysis 
has demonstrated increased mitochondrial DNA content and a spectrum of mitochondrial DNA 
mutations in glaucoma patients (Chrysostomou et al. 2013, Zhang et al. 2016, Van Bergen et 
al. 2015). In addition, many diseases caused by mutations in mitochondrial genes, or nuclear 
genes encoding mitochondrial proteins, primarily affect retinal ganglion cells and present as 
visual disorders with little or no extra-ophthalmic symptoms (e.g. MT-ND1, MT-ND4, MT-
ND6 in Leber’s hereditary optic neuropathy; OPA1 in autosomal dominant optic atrophy (Yu-
Wai-Man, Griffiths, and Chinnery 2011, Pilz, Bass, and Sherman 2017)), suggesting retinal 
ganglion cell sensitivity to mitochondrial perturbations (Williams et al. 2012). 
The majority of cells in our SBFSEM datasets were devoid of dendrites, which likely arose 
from the delay between death and fixation, where further neuronal degeneration may have 
occurred. We have previously demonstrated that axotomised rodent retina maintained in 
culture following extraction exhibit dendritic atrophy within 6 hours (Binley et al. 2016). 
However, fresh, axotomised human retina explant tissue culture has proven to be a useful tool 
to assess neurodegenerative insults and treatments despite this initial wave of degenerative 
changes (Osborne, Hopes, et al. 2016, Osborne, Sanderson, and Martin 2018). The mean time 
from death to fixation was shorter in the glaucoma eyes compared with controls (3.1 ± 1.1 
hours and 7.33 ± 1.2 hours) while control eyes were from older donors than glaucoma eyes. It 
is therefore reasonable to consider that dendritic degeneration may have been underestimated 
in the glaucoma eyes. Multiple regression analysis demonstrated that time from death to 
fixation may have contributed to changes in dendritic volume, but the differences observed 
between control and glaucomatous retinal ganglion cells were predominantly related to factors 
other than tissue preparation. Intact, albeit degenerated dendrites, are an indication that 
potentially functional cells remain in regions of the retina which have no-to-moderate cell loss 
and visual deficits. 
We observed a reduction in the number of mitochondria, with changes in size, shape, and 
distribution across the dendritic tree. We also observed an increase in double membranous 
structures which likely include vacuoles, granulovacuolar degeneration bodies, and 
mitochondria devoid of cristae structure. While these structures are characteristic of 
neurodegenerative processes, we cannot exclude the possibility that they occur as part of the 
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normal aging process (as these eyes came from significantly aged individuals) or that the rate 
and magnitude of the appearance of these structures differs in a disease context. Since they 
were also present in control tissue, it is possible that they are artefacts arising from the delay 
in death-to-fixation and the storage of tissue long term in PFA (as opposed to osmium tetroxide 
or cacodylate buffer as standard in electron microscopy preparations). Multiple regression 
analysis demonstrated that differences in tissue fixation time had no significant relationship to 
mitochondria or vacuole variance but time from death to fixation may have contributed to 
changes in vacuole volume. This suggests that the difference between control and 
glaucomatous retinal ganglion cell vacuole volume may be overestimate, but it remains 
predominantly related to factors other than tissue quality. However, the definitive evaluation 
and staging of this process would require tissue available at postmortem stages that are 
unrealistic. Conservatively, our data support the neurodegenerative processes observed in 
animal models. Further studies with larger numbers of eyes would be required to provide more 
detailed quantification of the relationship between these degenerative changes and visual 
dysfunction. 
The compartmentalized degeneration of retinal ganglion cells results in functional visual loss 
in animal models of glaucoma (Howell et al. 2007, Della Santina et al. 2013, Weber and 
Harman 2005). These data suggest that in humans, early degenerative changes prior to gross 
axon and soma loss, contributes to vision loss. The ‘hockey-stick’ model of Swanson et al. 
(Swanson, Felius, and Pan 2004) predicts that the rate of change in sensitivity with respect to 
retinal ganglion cell number is low when the stimulus is larger than the critical summation area, 
but becomes greater when the stimulus is smaller than the critical summation area. This model 
applies in healthy observers as the critical summation area enlarges with increasing 
eccentricity, encompassing a constant number of retinal ganglion cells. Although it is known 
that the critical summation area is enlarged at fixed locations in the visual field in glaucoma 
(Redmond et al. 2010), the range over which it can enlarge is unknown. The steeper than 
expected drop-off in sensitivity at lower retinal ganglion cell densities observed in the present 
study (Figure 1D), would suggest that the range of enlargement is shorter in glaucoma than 
that observed across eccentricities in healthy controls. A number of difficulties with the 
limitations of Standard Automated Perimetry and cell counting may have contributed to the 
discrepancy found in the current study. Inter- and intra- test variability substantially increase 
with depth of visual field defect (Artes et al. 2002, Henson et al. 2000) which may increase 
variance in the functional data. Fixational drift and microsaccades can vary the location of 
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individual stimuli (Henson et al. 1996), and if retinal ganglion cell loss is heterogeneous, this 
could manifest as greater variability in sensitivity measurements. Pre-neuronal abberations 
(e.g. optical defects) could also influence sensitivity. Nuclear counts will not distinguish 
between functional retinal ganglion cells and those with reduced or absent visual input (i.e. 
synapse and axon loss; which we addressed further in our SBFSEM studies presented here). 
The interval from the last visual field to time of death was 7-21 months, in which time retinal 
ganglion cell degeneration could have progressed, but given that regions of no significant cell 
loss demonstrated a visual deficit, this seems an unlikely source of discrepancy. The degree of 
cell loss within visual field test areas has previously been shown to have a weak relationship 
with visual sensitivity (R2 = 0.31) (Kerrigan-Baumrind et al. 2000). In these experiments cell 
counts of 4 retinal sections from 28 test locations were conducted across 17 eyes, however 
these data are caveated as the linear regression fits were calculated against sensitivity (dB scale; 
a log scale) without log scaling of retinal ganglion cell number, and performed on retinal 
sections rather than whole-mounted retina. The present study suggests that visual field 
sensitivity is lower, overall, than expected from the ‘hockey-stick’ model for a range of retinal 
ganglion cell densities, with considerable variance in the sensitivity data, particularly in 
locations with lower retinal ganglion cell density. Taken together, the findings of the current 
study suggest that in glaucoma, deficits at the level of the single cell may initially be masked 
when retinal ganglion cell density is high and contribute to the steeper than expected drop-off 
in sensitivity when the density is low. 
The detection of the earliest signs of retinal damage remain a sought after target for clinicians 
managing glaucoma. The detection of retinal ganglion cell apoptotic events using fluorescent 
annexin-V tagging suggests one possibility (Cordeiro et al. 2017, Cordeiro 2007). However, 
the cells identified by this method are already undergoing cell death, the temporal dynamics of 
which are still unresolved, and are therefore unlikely to be targets for functional recovery. The 
demonstration of changes in dendritic and mitochondrial structure and distribution in the 
present study suggest that these may present a clinically detectable target of early retinal 
neuronal damage. While these structures fall within the theoretical detection limit for high 
resolution OCT (Morgan et al. 2017) direct imaging is unlikely in view of their relatively low 
contrast. However, changes in optical scatter induced by neurodegenerative changes in the 
inner retina are a realistic target. We have demonstrated that changes in optical texture of the 
inner plexiform layer can be detected by high resolution OCT and correlated with histological 
changes in retinal explants (Tudor et al. 2014). Preliminary work in human glaucoma suggests 
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that optical texture, as derived by OCT, can support the early diagnosis of glaucoma 
(Anantrasirichai et al. 2013). In addition, there is increasing evidence for the detection of 
Alzheimer’s disease by OCT of the inner retina (Liao, Zhu, and Peng 2018, den Haan et al. 
2017). Mitochondrial loss has been reported in retinal ganglion cells in mice carrying 
Alzheimer’s disease associated mutations (Williams, Thirgood, et al. 2013) and may therefore 
also provide optical texture changes for earlier and more sensitive detection of Alzheimer’s 
disease. 
In conclusion, we demonstrate a proof-of-concept, first-in-glaucoma, high resolution analysis 
of glaucomatous retinal ganglion cells permitting the analysis of dendritic and mitochondrial 
structures. Further studies with an increased number of cells across various glaucoma 
pathologies will allow the delineation of the extent to which these changes are common across 
glaucoma sub-groups. 
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Figures and Figure Legends
Figure 1: Retinal ganglion cell loss assessed in relation to visual field deficits
Human donor eyes from glaucoma donors (n = 4) complete with visual field tests conducted 
prior to death (A; upper row) were analyzed in comparison to control donor eyes (n = 6). Whole 
retinas were imaged by 2-photon microscopy and cell counts made in regions of the retina 
corresponding to visual field test locations (A; lower row). Regions were numbered 1-72 
beginning superior-temporally, with regions that correspond to visual field test locations 
highlighted (purple shading; n = 54 locations). Following imaging, 11 regions were dissected 
out and processed for SBFSEM (magenta boxes). (B) Retinal ganglion cell densities were 
estimated for each test location from z-stack counts within an en face area of 350 µm2 and 
expressed as cells / mm2. Density plots for each glaucomatous retina (B; upper row) with 
corresponding percentage change from average control density at each region (B; lower row). 
Region locations are inverted along the superior to inferior axis to correspond to the visual field 
plots (as the superior retina views the inferior visual field and vice versa). Retinal ganglion cell 
density change against eccentricity was plotted for control (C; left panel) and glaucoma eyes 
(C; right panel). The relationship between retinal ganglion cell density (expressed as log10 cells 
/ area of the stimulus (Goldman III)) and visual sensitivity is plotted in D. There was no 
correlation when retinas were grouped as shown by linear regression (Spearman’s rho, r = 
0.23, P < 0.001; D). Individual retinas show high variation among eyes (D). The ‘hockey-stick’ 
model fitted by Swanson et al. (Swanson, Felius, and Pan 2004) to a plot of normal visual field 
sensitivity, corrected to a 34 year old (Heijl, Lindgren, and Olsson 1987) against normal retinal 
ganglion cell counts (Curcio and Allen 1990) is superimposed on the data from the current 
study in D (red line). Individual retinas show a similar relationship when retinal ganglion cell 
density is high, but a greater than expected drop off in sensitivity when cell density is low. 
Retinal ganglion cell abbreviated to RGC in B-D. For A, F = fovea, ON = optic nerve; retinal 
orientation identified by N = nasal, I = inferior, S = superior, T = temporal. Retinal ganglion 
cell density scales through low (purple) to high (yellow) (B; upper row). Retinal ganglion cell 
density change scales through +100% of control average (purple) to -100% of control average 
(yellow) (B; lower row). Black regions in B represent regions around the optic nerve where 
cell counts were not taken.
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Figure 2: Dendritic loss is a feature of human glaucoma
Retinal samples (n = 5 from glaucoma; (4 eyes), and n = 6 from controls; (4 eyes) 
corresponding to visual field test locations were dissected and prepared for SBFSEM. 
Volumetric EM data were generated (A) from 79 x 79 x 100 µm tissue cube (19.2 x 19.2 x 100 
nm resolution). A representative single slice (x-y plane) is shown in panel B (cropped in x) 
showing the retinal layers analysed. Retinal ganglion cells were identified and their dendrites 
reconstructed within the IPL. A cartoon of a Golgi stained midget cell is shown for comparison 
in panel C alongside a reconstruction from the current SBFSEM data (for more examples see 
(Kolb and Dekorver 1991)). Seven control (D, upper panel) and five glaucomatous (D, lower 
panel) retinal ganglion cells that met inclusion criteria were reconstructed. Dendrites (yellow) 
and synapses (cyan) are shown, with the dendrite origin at the soma indicated (white 
arrowheads). Analysis of dendrites demonstrated reduced dendritic branching (E) and fewer 
and shorter secondary and tertiary dendrites in glaucoma, indicating the presence of dendritic 
atrophy (F and G; primary dendrites n = 5 in glaucoma, n = 7 in controls; secondary dendrites 
n = 4 in glaucoma, n = 14 in control, tertiary dendrites n = 0 in glaucoma, n = 3 in control). . * 
= P < 0.05, NS = non-significant (P > 0.05). For B, ILM = inner limiting membrane, NFL = 
nerve fiber layer, GCL = ganglion cell layer, IPL = inner plexiform layer, INL = inner nuclear 
layer. Scale bar = 5 μm for D.
Figure 3: Mitochondrial morphometry and distribution are altered in human glaucoma
Organelles from five glaucomatous (n = 4 eyes) and 7 control retinal ganglion cells (n = 4 eyes) 
were reconstructed in FIJI (ImageJ). Mitochondria (mitos, magenta; identified by the presence 
of cristae; n = 198 in controls, n = 55 in glaucoma across all cells analysed) and vacuoles 
(green, double membranous structures devoid of cristae and electron dense material; n = 273 
in controls, n = 326 in glaucoma across all cells analysed) were reconstructed within retinal 
ganglion cell dendrites (yellow). Representative EM images for control (A) and glaucoma (C) 
and reconstructions (B and D) are shown. The number of mitochondria per µm of dendrite for 
individual retinal ganglion cells was reduced in glaucoma (E) and mitochondria occupied a 
reduced percentage of dendritic volume in glaucoma compared to controls (F). Sholl analysis 
of mitochondria demonstrates that the mitochondrial distribution across dendrites was altered 
in glaucoma when expressed as a distribution statistic for primary dendrites (G; Fisher’s exact 
test; for individual dendrites, n displayed in figure), secondary dendrites (H; Fisher’s exact 
test), but not tertiary dendrites (I; Fisher’s exact test). When expressed as Sholl AUC (J), 
mitochondrial distribution is significantly changed in secondary dendrites in glaucoma 
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compared to controls but not for primary and tertiary dendrites. Nearest neighbor distance 
analysis (NND) demonstrated no significant change in the proximity of mitochondria to one 
another in primary dendrites (K; mitochondria n = 39 in controls, n = 38 in glaucoma) but a 
significant isolation in secondary dendrites (distances to the 1st, 2nd and 3rd nearest neighbors 
(k = 1-3) increased) (L; mitochondria n = 151 in controls, n = 17 in glaucoma). There were no 
observable mitochondria in tertiary dendrites in retinal ganglion cells from glaucoma eyes (M). 
Individual mitochondrial surface reconstructions were generated in Imaris (mitochondria n = 
149 in controls, n = 55 in glaucoma), representative images are shown for control and 
glaucomatous retinal ganglion cells (N). Mitochondria demonstrated significantly reduced 
volumes in glaucoma (O) and were more spherical compared to controls (P). Oblate (rounded) 
and prolate (cigar-shaped) ellipticity was not significantly altered (Q). Sholl analysis of 
vacuoles across the dendritic tree as a whole demonstrated a significant change in distribution 
(R; Fisher’s exact test) but not in the Sholl AUC (S). The number of vacuoles per µm of 
dendrite was increased in glaucoma (E) but the percentage of dendritic volume occupied by 
vacuoles was unchanged (F). Nearest neighbor distances in vacuoles for the k = 3 nearest 
neighbors decreased significantly in glaucoma indicating an increased density of vacuoles (T; 
vacuoles n = 273 in controls, n = 326 in glaucoma). * = P < 0.05, ** = P < 0.01, *** = P < 
0.001, NS = non-significant (P > 0.05). Scale bar = 5 μm for B and D, and 3 μm for N. 
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Tribble et al. demonstrate midget retinal ganglion cell dendritic degeneration coupled with remodeling 
and redistribution of mitochondria as features of human glaucoma. These changes may contribute to 
changes in visual sensitivity during disease progression and extend the similarities between human 
glaucoma patients and animal models of glaucoma.
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